Dihydrolipoyl Transacetylase (DLAT) Peptide
Aperçu rapide pour Dihydrolipoyl Transacetylase (DLAT) Peptide (ABIN937613)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- DVVSLATKAR EGKLQPHEFQ GGTFTISNLG MFGIKNFSAI INPPQACILA
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DLAT antibody,
Alternative Names: DLAT control peptide, DLAT antibody Blocking Peptide, Anti-DLAT Blocking Peptide, Dihydrolipoamide S-Acetyltransferase Blocking Peptide, DLTA Blocking Peptide, PDC-E2 Blocking Peptide, PDCE2 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Sujet
- DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.
-
Poids moléculaire
- 69 kDa
Antigène
-